Rhabdomyosarcoma is the most common malignant soft tissue sarcoma seen in the pediatric population. Large cooperative therapeutic studies have contributed to the advances seen in risk stratification and classification based on cytogenetics have led to improvements in the treatment, morbidity, and survival. Molecular profiling has supplanted the role of histopathologic examination in risk stratification. Current treatment strategies include a multimodal approach with a combination of systemic chemotherapy, radiation therapy, surgical resection of the tumor, and surgical evaluation of regional lymph nodes.
|Title of host publication||Fundamentals of Pediatric Surgery, Third Edition|
|Number of pages||8|
|State||Published - Jan 1 2022|
Bibliographical notePublisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.
- Soft tissue sarcoma
- Solid tumor
- Surgical oncology
ASJC Scopus subject areas
- Medicine (all)
- Nursing (all)